Merck & Co., Inc.  

(Public, NYSE:MRK)   Watch this stock  
Find more results for MRK
58.58
+0.04 (0.07%)
After Hours: 58.58 0.00 (0.00%)
Mar 2, 5:26PM EST  
NYSE real-time data - Disclaimer
Currency in USD
Range 58.28 - 58.89
52 week 52.49 - 63.62
Open 58.29
Vol / Avg. 9.67M/10.06M
Mkt cap 166.98B
P/E 14.28
Div/yield 0.45/3.07
EPS 4.10
Shares 2.85B
Beta 0.35
Inst. own 75%
Apr 28, 2015
Q1 2015 Merck & Co Inc Earnings Release - 9:30AM EDT - Add to calendar
Apr 28, 2015
Q1 2015 Merck & Co Inc Earnings Call - 8:00AM EDT - Add to calendar
Mar 11, 2015
Merck & Co Inc at Barclays Healthcare Conference - 8:00AM EDT - Add to calendar
Mar 3, 2015
Merck & Co Inc at Cowen Health Care Conference - 8:40AM EST - Add to calendar
Feb 23, 2015
NGM and Merck & Co Inc Announce Broad Strategic Collaboration Call
Feb 4, 2015
Q4 2014 Merck & Co Inc Earnings Release
Feb 4, 2015
Q4 2014 Merck & Co Inc Earnings Call - Webcast
Jan 12, 2015
Merck & Co Inc at JPMorgan Healthcare Conference - Webcast
Dec 8, 2014
Merck & Co Inc to Acquire Cubist Pharmaceuticals Inc Call for Media
Dec 8, 2014
Merck & Co Inc to Acquire Cubist Pharmaceuticals Inc Call
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 69.90% 28.25%
Operating margin 11.23% 13.42%
EBITD margin - 50.73%
Return on average assets - -
Return on average equity - -
Employees 76,000 -
CDP Score - 88 B

Address

2000 Galloping Hill Rd
KENILWORTH, NJ 07033-1310
United States - Map
+1-908-7404000 (Phone)
+1-908-4231987 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Merck & Co., Inc., is a health care company. The Company delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company�s operations are principally managed on a products basis and are comprised of four operating segments, which are the Pharmaceutical, Animal Health, Consumer Care and Alliances segments. The Pharmaceutical segment includes human health pharmaceutical and vaccine products consisting of therapeutic and preventive agents, sold by prescription, for treatment of human disorders. The Company has animal health operations that discover, develop, manufacture and market animal health products. The Consumer Care develops, manufactures and markets over-the-counter, foot care and sun care products.

Officers and directors

Kenneth C. Frazier Chairman of the Board, President, Chief Executive Officer
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert M. Davis Chief Financial Officer, Executive Vice President
Age: 47
Bio & Compensation  - Reuters
Clark Golestani Executive Vice President, Chief Information Officer
Age: 47
Bio & Compensation  - Reuters
Michael J. Holston Executive Vice President, Chief Ethics and Compliance Officer
Age: 51
Bio & Compensation  - Reuters
Bruce N. Kuhlik Executive Vice President, General Counsel
Age: 57
Bio & Compensation  - Reuters
Mirian M. Graddick-Weir Executive Vice President - Human Resources
Age: 59
Bio & Compensation  - Reuters
Willie A Deese Executive Vice President, President - Merck Manufacturing Division
Age: 58
Bio & Compensation  - Reuters
Richard R. DeLuca Jr. Executive Vice President, President - Merck Animal Health
Age: 51
Bio & Compensation  - Reuters
Cuong Viet Do Executive Vice President, Chief Strategy Officer
Age: 47
Bio & Compensation  - Reuters
Julie L Gerberding Executive Vice President - Strategic Communications, Global Public Policy & Population Health
Age: 59
Bio & Compensation  - Reuters